Clinical Trial Update: Safety, Pharmacokinetics (PK), and Efficacy of ONC 841 in Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial to evaluate safety, pharmacokinetics, and preliminary efficacy of ONC 841 in patients with advanced solid tumors; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• ONC 841

Snippet

Sponsor: OncoC4, Inc. | Conditions: Advanced Solid Tumor | Phase 1 | Status: RECRUITING